Compare LFVN & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFVN | JMM |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 55.8M |
| IPO Year | 1996 | N/A |
| Metric | LFVN | JMM |
|---|---|---|
| Price | $9.77 | $5.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 541.6K | 14.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 3.56% | ★ 5.44% |
| EPS Growth | ★ 226.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.03 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $5.67 |
| 52 Week High | $15.00 | $6.52 |
| Indicator | LFVN | JMM |
|---|---|---|
| Relative Strength Index (RSI) | 74.02 | 46.77 |
| Support Level | $4.86 | $5.70 |
| Resistance Level | $14.28 | $5.88 |
| Average True Range (ATR) | 1.31 | 0.05 |
| MACD | 0.33 | 0.01 |
| Stochastic Oscillator | 69.87 | 50.00 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.